This HTML5 document contains 114 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.3389/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q98224491
rdf:type
wikibase:Item
schema:description
scientific article published on 14 July 2020 наукова стаття, опублікована 14 липня 2020 wetenschappelijk artikel im Juli 2020 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en xunetu de 2020
p:P577
wds:Q98224491-2FE111FD-6377-435E-9AD7-22D4620D71B4
wdt:P577
2020-07-14T00:00:00Z
p:P2860
wds:Q98224491-05283199-2C8E-4993-8306-D992C8B25A28 wds:Q98224491-00AF8551-21B9-4969-8352-79A6ECEDCEF2 wds:Q98224491-0BC3C428-B708-4575-A23C-1FC9BD5726C0 wds:Q98224491-05CADA81-FBD3-4ACF-A430-A3CC03E646EC wds:Q98224491-13567ED3-D6DD-4ECE-B0D0-C927698E5B2F wds:Q98224491-4A87CF5A-2E25-4076-993D-0B04C7E4395C wds:Q98224491-43C8824C-7F25-4C5F-BBB5-568BAB493682 wds:Q98224491-5160977A-EE2E-4EDF-909B-8128C7EE720B wds:Q98224491-6E7D9D51-8FDB-444E-9917-5D4002D98E47 wds:Q98224491-6EE58390-717E-4A01-A77B-26A1ADE8DD57 wds:Q98224491-7B032595-F9F2-4F5B-AA74-D4D6E5763684 wds:Q98224491-8A8276D6-06CC-4B0C-8562-0685D6946FB8 wds:Q98224491-83408769-5DF1-460F-AF1C-FB5C74EFEEFF wds:Q98224491-8CEF3941-A0A2-4C9D-A7EF-AFB9FD4EAB94 wds:Q98224491-8B1A70F6-C620-46E2-B15B-EBF192F39D1D wds:Q98224491-931C535F-AAFE-41E3-94ED-41F39B4CC40B wds:Q98224491-8E33D715-1E3B-4410-A01C-020CE0D3CC48 wds:Q98224491-9D1C5B8E-8C1D-45B3-B726-1AEB7D75EC47 wds:Q98224491-AB48061D-4718-48BE-8414-57B7A6DAA119 wds:Q98224491-BAC49849-4D4D-4BA7-B77C-CCF16B232E6D wds:Q98224491-BA435D0A-2428-482D-90D8-A2F726B52677 wds:Q98224491-BDA61D96-2DF0-42D8-9181-90A263967E84 wds:Q98224491-BADC5197-49C8-4E16-B459-B0E2C14A67E7 wds:Q98224491-D590EFCD-BB50-484E-81F9-82CAFC2CA126 wds:Q98224491-C7401488-6AD7-4193-9479-DF26AA0E02F2 wds:Q98224491-D894E2EC-D855-4EC9-A738-BAFAE7E39B49 wds:Q98224491-D6155C3A-CBCB-4819-A2A4-B5E44C2C1A2C wds:Q98224491-DF98EEA6-9626-48FC-B5CB-DA5CB71BD288 wds:Q98224491-DB77C788-026E-4295-AE91-0222E55148C4 wds:Q98224491-E5138A9E-6ACF-40EF-83C8-101F6313165C wds:Q98224491-EE602645-B5DF-4EF3-AA4F-0CD9A499BBD7 wds:Q98224491-FFEA8B56-5CE0-46CB-8AB8-CEA912C4D39C
wdt:P2860
wd:Q36013705 wd:Q92414533 wd:Q91047208 wd:Q54430437 wd:Q70580981 wd:Q34130671 wd:Q37978861 wd:Q58234722 wd:Q35547604 wd:Q38089474 wd:Q34148153 wd:Q26771463 wd:Q50068956 wd:Q54443176 wd:Q36229192 wd:Q91563212 wd:Q64252708 wd:Q91938966 wd:Q53668242 wd:Q38460407 wd:Q37001999 wd:Q33399862 wd:Q36758489 wd:Q39243711 wd:Q39265436 wd:Q34566407 wd:Q73182317 wd:Q57231946 wd:Q38096294 wd:Q33766404 wd:Q58911369 wd:Q39701973
p:P2093
wds:Q98224491-E4611CDA-8BC6-4756-B682-2EE6F54CD9B5 wds:Q98224491-2D03D6EB-B699-4E9F-A266-3C1066C47616 wds:Q98224491-149F852E-E262-4F70-B7DB-EDF5C77E7FB8 wds:Q98224491-69267C70-D700-4426-A5FE-286CF4173332 wds:Q98224491-54BB9089-7DBA-4B09-A923-0FDBD81E84AA wds:Q98224491-E6B27B0C-D1AB-4B35-B239-169ED5F33183
wdt:P2093
Giovanni Giorli Francesca W Rossi Amato de Paulis Felice Rivellese Filomena Napolitano Costantino Pitzalis
rdfs:label
Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
skos:prefLabel
Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
schema:name
Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
p:P1476
wds:Q98224491-B82A1FDB-B08E-4B69-B739-6716C6F9CCB1
wdt:P1476
Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
p:P304
wds:Q98224491-978F5161-8646-467C-8E7B-46FB33C58F37
wdt:P304
1051
p:P31
wds:Q98224491-7EA20D01-7EA3-42B3-A1A7-E845465EA699
wdt:P31
wd:Q13442814
p:P921
wds:Q98224491-B12DF0E0-F9EB-48FE-B511-DCB5A4D6ACE2
wdt:P921
wd:Q187255
p:P698
wds:Q98224491-21705DCB-E467-4778-9F2B-DF0593879836
wdtn:P698
n12:32760275
wdt:P698
32760275
p:P1433
wds:Q98224491-C3BBBB40-9C29-4B02-A6D9-7D671561C246
wdt:P1433
wd:Q2681208
p:P478
wds:Q98224491-A43E3D24-4400-48D2-A1A3-3D826F7F64F1
wdt:P478
11
p:P356
wds:Q98224491-40E5581C-0BC0-49B9-B194-647F0C141B7B
wdtn:P356
n11:FPHAR.2020.01051
wdt:P356
10.3389/FPHAR.2020.01051
p:P275
wds:Q98224491-ac1c20ff-06fc-404a-93c0-1f98e940476f
p:P6216
wds:Q98224491-72b058ea-b943-42b0-8949-69c6c07f9ab0
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q98224491-C0FDF064-5D85-4FB0-9AA1-377B6EACBD3E
wdt:P932
7371927